http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020238148-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ae3ff27b64d8d6516ec5127c1ac829
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac09a16d1d70190e7d9cb4bde8b4c3a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f76d50add70aa62a4e13c84d0878a3d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fc1dd0937380ce7ab4636fa71fad82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9bea3734409cabcd4df15eb3d96222
publicationDate 2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020238148-A1
titleOfInvention Ethanol foam hardener applied to treatment of vascular anomalies and preparation method
abstract An ethanol foam hardener applied to the treatment of vascular anomalies and a preparation method, comprising absolute ethanol, water, Tween 80, and a stabilizer. Further comprised is hyaluronic acid. The ethanol foam hardener comprises 32-42% absolute ethanol, 0.5-2% Tween 80, 0-25 (not comprising 0) egg yolk lecithin, 0-2% (not comprising 0) hyaluronic acid, and the remainder is water. The stabilizer is hyaluronic acid or glycerin. A Tessari method is used to prepare foam, which may significantly reduce the side effects of ethanol while not changing the original therapeutic effects of the ethanol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114558124-A
priorityDate 2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451849165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452

Total number of triples: 44.